-
A protein called the alpha-7 receptor could be key in developing drugs for medical conditions and diseases including obesity, schizophrenia, and Alzheimer"s disease. The protein is found on brain cells and is known to cause nicotine addiction. The protein interacts with 55 other proteins including a separate class of receptor that is a target for about 40 percent of all therapeutic drugs. Accord
제약단신
메디칼라이터팀
2009.07.01 00:00
-
A federal jury in Texas ordered Abbott Laboratories to pay $1.6 billion for infringing on the patent of Johnson & Johnson"s arthritis treatment Remicade [infliximab]. J&J had claimed that Abbott"s Humira [adalimumab] infringed a patent that J&J"s Centocor Ortho Biotech unit held for rival treatment Remicade while Abbott claimed that the patent doesn"t cover the human antibodies used in Humira.
제약단신
메디칼라이터팀
2009.07.01 00:00
-
Food and Drug Administration approved Teva Pharmaceutical Industries Ltd. and Antares Pharma Inc. use of the human growth hormone Tev-Tropin [somatropin] in a needle-free injection system. The system allows for rapid injection speed without the use of a needle.
제약단신
메디칼라이터팀
2009.07.01 00:00
-
Researchers at Children"s Hospital of Pittsburgh are hoping to control type 1 diabetes by making a vaccine out of the patient"s own blood. In human trials by using donated blood researchers could filter out immature dendritic cells and then reprogram them.
제약단신
메디칼라이터팀
2009.07.01 00:00
-
At a two-day FDA meeting 35 experts discussed ways to prevent overdose with acetaminophen which included reducing the maximum daily and single doses. Another possiblity is taking products combining acetaminophen with other drugs off the market. Acetaminophen is known to cause liver failure and the difference between a harmful dose and a recommended dose is small. McNeil Consumer Healthcare is con
제약단신
메디칼라이터팀
2009.07.01 00:00
-
Research published in the journal Nature show that rapamycin seemed to boost the number of "memory" T cells that remember the infections they have encountered before. The study, involving tests on mice and monkeys, also suggests that the protein, mTOR plays a key role in regulating the generation of memory T cells and according to Professor Adrian Hill, director of the Jenner Institute, could be
제약단신
메디칼라이터팀
2009.06.30 00:00
-
The Obama administration supports legislation that generic drugs should be protected from competition for 7 years. The industry has said it wants 12-14 years but according to the the Federal Trade Commission delay innovation and patients" access to cheaper drugs. This compomise is of interest to Debra Barrett, vice-president for government affairs at Teva Pharmaceuticals (TEVA). The company has
제약단신
메디칼라이터팀
2009.06.30 00:00
-
Chris Viehbacher, the chief executive of Sanofi-Aventis, is playing down suggestions of a large scale merger while indicating that Sanofi is interested in expanding its consumer and animal health divisions. Sanofi will not outsource manufacturing like other companies and is also in the position to broaden its geographical and product ranges including the acquisition of generic drug companies.
제약단신
메디칼라이터팀
2009.06.30 00:00
-
Roche has stopped selling its acne drug Accutane [isotretinoin]as sales have fallen since its patent expired in 2002. Roche maintains that the decision was made for economic reasons as generic versions are now on the market although the drug has also been the subject of several lawsuits. The company has been faced with high costs from personal injury. Juries awarded $33 million in damages to users
제약단신
메디칼라이터팀
2009.06.30 00:00
-
A study published in the journal, Diabetologia, showed that 127,000 patients treated with Lantus [insulin glargine] statistically showed a link to being diagnosed with cancer. A Swedish study showed that patients treated with the Sanofi drug, Lantus, had twice the risk of breast cancer while both Scottish and UK studies showed non-signicant increases. The European Association for the Study of Diab
제약단신
메디칼라이터팀
2009.06.30 00:00
-
The European Medicines Agency has recommended gradually withdrawing dextropropoxyphene-containing painkillers, from the market, such as Darvon and Darvocet, as they have been linked to fatal overdose. The EMEA has not clarified how many people have died either accidentally or intentionally. In the US the drug is known by the generic name propoxyphene. Advisers to the FDA suggested removing it fro
제약단신
메디칼라이터팀
2009.06.27 00:00
-
The Food and Drug Administration says Tylenol [acetaminophen] is safe if taken at recommended levels. Federal regulators and medical experts will debate how to limit liver injury in patients who take the medicines next week. Consumers are unaware that the same ingredients are prevalent in pain relievers, fever reducers, and cough medicines. If they are taking a variety it can lead to accidental ov
제약단신
메디칼라이터팀
2009.06.27 00:00
-
FDA seized drugs and raw ingredients from three Caraco Pharmaceutical Laboratories Ltd facilities in Michigan, after inspectors from the Center for Drug Evaluation and Research, found serious deficiencies in manufacturing standards and quality control. The seizure could lead to shortages of choline magnesium trisalicylate, a generic pain-relief medication. Although Caraco manufactures 33 drugs tha
제약단신
메디칼라이터팀
2009.06.27 00:00
-
Results of a study of 169 patients suffering from pancreatic islet cell tumors were presented at the World Congress on Gastrointestinal Cancer. Participants were randomized and either received 37.5mg/day of Sutent [sunitinib] or placebo. All participants had progressed over the previous 12 months and were receiving the best care. According to results patients treated with Pfizer"s drug, Sutent,
제약단신
메디칼라이터팀
2009.06.27 00:00
-
The ActHIB and Pentacel Hib vaccines by Sanofi Pasteur are now available so the FDA recommend children be given their Haemophilus influenzae type B (Hib) booster doses which have been delayed due product suspension of Merck"s PedvaxHIB and Comvax. The company had received warnings that it breached manufacturing rules between November 2007 and January 2008 at its West Point, PA plant. All infants
제약단신
메디칼라이터팀
2009.06.27 00:00
-
미국심장협회(AHA)가 음악을 통한 심혈관질환 재활의 가능성을 제시했다. 이탈리아 파비아대학(Pavia University) 루치아노 베르나르디(Luciano Bernardi) 교수는 이전의 템포가 빠른 음악이 호흡, 심방박동, 혈압의 증가를 야기했다는 연구(Heart. 2006 Apr;92(4):445-52)의 후속연구 결과를 발표, 음악이 신체의 심혈환 시스템과 동조하며 이를 적용해 심혈관 환자의 재활에 사용할 수 있을 것이라고 말했다.연구팀은 24~26세 사이의 24명을 음악군과 비음악군으로 나눠 음악에 따른 심장박동, 호흡, 혈압, 피부혈관운동, 중간대뇌동맥 혈류 등을 측정했다. 결과 점점 강해지는 크레센도(cresendos) 음악은 중등도의 자극을, 반대인 디크레센도(decrescendos) 음악은
제약단신
임세형 기자
2009.06.26 00:00
-
환자의 검사결과는 당연히 환자 자신에게 전달돼야 하지만 최근 연구에서는 비정상적인 검사결과들 중 약 7%가 환자에게 전해지지 않는 것으로 나타났다. 뉴욕 웨일코넬의대(Weill Cornell Medical college) 로렌스 카사리노(Lawrence Casalino) 교수는 검사결과 전달에서 발생하는 오류를 줄이기 위해서는 의료기록 방식의 단일화가 필요하다고 지적했다.연구팀은 50~69세 5434명의 고콜레스테롤, 당뇨병, 결장암 혈액검사, 유방암 X-ray 검사 등 선별검사 자료를 검토했다. 이와함께 1차 의료기관 의사를 대상으로 검사결과의 관리과정에 대해 알아봤다. 결과 비정상적인 검사결과에 대한 정보나 서류가 환자에게 전달되지 않은 비율은 7.1%였다. 또한 검사에 따라 0~26.2%의 차이를 보였
제약단신
임세형 기자
2009.06.26 00:00
-
미국 버락 오바마(Barack Obama) 대통령의 담배규제안 서명에 미국 의학계가 환영의 뜻을 표했다. 담배규제안은 오바마 대통령이 상원의원일 때부터 강력하게 추진해온 부분이기도 하지만 미국심장협회(American Heart Association)와 미국폐학회(American Lung Association)가 약 10여년 동안 지지해온 법안이기도 하기 때문. 이번 법안은 청소년을 타깃으로 한 담배의 홍보금지, 흡연의 유해성 강조 등 흡연인구 감소와 흡연관련 질병의 유병률 감소를 목적으로 하고 있다.미국심장협회 티모시 가드너(Timothy Garder) 회장은 "이 날은 역사적인 순간"이라며 "이 법안의 통과는 보건체계 개혁에 대한 탄력과 예방에의 관심 증가를 보여주는 것"이라고 말했다.미국심장협회·폐학회와
제약단신
임세형 기자
2009.06.26 00:00
-
신종 인플루엔자 A형(신종플루)의 변화추이에 세계 보건계가 촉각을 곤두세우고 있다. 세계보건기구(WHO)가 이번달 11일 팬데믹 경고수준을 6단계로 높인 가운데 신종플루의 전파력은 사그러들지 않고 있다. 이런 가운데 지난 17일 변종의 등장에 이어 세계 곳곳에서 2차 감염자와 치료 과정 중 사망자가 발생해 전문가들은 신종플루의 중증도의 변화에 관심을 모으고 있다. 이에 최근 독일 보건 당국은 "다음달 신종플루가 더 위험한 형태로 독일을 비롯한 유럽 내에 전파될 수 있다"는 전망을 발표해 전문가들의 우려를 대변했다. 독일 전염병연구소 로버트 코치(Robert Koch) 소장은 "현재 신종플루의 변이 가능성이 높은 가운데 가을에 변이된 바이러스가 북반구 지역에 유행할 수 있다"고 말했다. 또한 브라질 상파울루에
제약단신
임세형 기자
2009.06.26 00:00
-
Lawmakers in the House and Senate have introduced bills preventing branded drug companies from introducing their authorized generics within the first 180 days of competition between it and other rival generic drugs. An interim report by the US Federal Trade Commission indicates that drug costs are lowered in the short term providing savings to consumers and governments. The FTC would not say wheth
제약단신
메디칼라이터팀
2009.06.26 00:00